Epidermolysis bullosa hereditaria. Clinical trial with fluocinonide FAPG 0.05 percent in five cases.
D000085:Acetates; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D004820:Epidermolysis Bullosa / Q000188:drug therapy* / Q000235:genetics; D004952:Esters; D005233:Fatty Alcohols; D005260:Female; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009824:Ointments; D010166:Palliative Care; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols
D000085:Acetates; D004952:Esters; D005233:Fatty Alcohols; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D005446:Fluocinolone Acetonide